Reuters logo
India's Divi's Laboratories March quarter net up 22 pct
May 12, 2012 / 11:27 AM / 6 years ago

India's Divi's Laboratories March quarter net up 22 pct

 MUMBAI, May 12 (Reuters) - 	
  Three months ended March 31 versus the same period a year earlier
  (In billion rupees unless stated)
  Net Profit         2.2 vs 1.8
  Net Sales          7.2 vs 4.8
 
  Results are consolidated
 
  NOTE: Divi's Laboratories Ltd           is a drugmaker.
 	
 (Reporting by Shamik Paul; Editing by Toby Chopra)	
 

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below